ARTICLE | Clinical News
Valstar valrubicin regulatory update
February 7, 2000 8:00 AM UTC
Canada accepted for filing Anthra's new drug submission for Valstar, a chemotherapeutic for intravesical therapy of refractory carcinoma in situ of the bladder. PLB has exclusive rights in Canada to t...